Roche Holding AG has agreed to buy U.S. biotech company InterMune Inc for $8.3 billion in cash, marking the latest multibillion-dollar deal in a consolidating pharmaceutical sector.
Bio Tech
FTC Charges Makers of Lumosity App $2M for Deceiving Users
Lumos Labs has been charged a fine of $2 million by the FTC for their misleading claims on the benefits of using their app, Lumosity. The company claimed that the app could decrease or slow down serious mental conditions by frequently using the app.
German Scientist Extracts Smart Phone Ingredient from Plants
German scientists came up with a method to extract from plants an element used for smartphones. thisd element is called Germanium and it can be found in plants that serve as a semi-conductor. It was used to create the first transistor since it can transport electrical charges very fast. Now, scientists from Germany found a way to extract it from plants.
UK man gets first bionic eye to restore sight
An 80-year old pensioner from Manchester, England has been fitted with a functioning bionic eye, restoring his central vision after a decade of partial sightedness.
Despite Third Point, low expectations for Amgen breakup
Amgen Inc (AMGN.O), one of the world's largest biotechnology companies, will unveil next week its first strategy update since early 2013, but few expect a major shift like the split-up recently proposed by Daniel Loeb's Third Point hedge fund.
Latest News
The US National Institutes of Health has awarded Oraya Therapeutics with a $215,000 Small Business Technology Transfer Grant to investigate gold nanoparticles development.
Seattle-based Juno Therapeutics announced it has closed Series B round of funding with $134 million. The new funding came from previous investors including ARCH Venture Partners, Alaska Permanent Fund, Bezos Expedition, the personal investment company of Amazon founder Jeff Bezos, and Venrock. Also participating in Series B are 10 other mutual funds and healthcare-related funds that wish to remain anonymous.
Response Genetics recently closed a credit agreement with SWK Funding for a multi-draw loan term of up to $12 million. The creditor has advanced the company $8.5 million, which is due on July 30, 2020, while the rest can be withdrawn once predetermined revenue milestones are reached.
Enumeral Biomedical Holdings announced that it had completed a merger between the company and its subsidiary, Cerulean Group, Inc. Along with the news of the merger, the company also announced the conclusion of its private placement financing, which raised $21.5 million.
Destiny Pharma recently announced in a press release that it was able to raise £2.8 million to fund the clinical trial of a drug aimed to prevent post-surgical infections. The company's recent funding, which was led by British government-backed Angel CoFund, will aid
The MIT Technology Review has recently released its list of the top companies from different fields of industry who have made impressive strides in its fields. The list showed companies who made dramatic developments in different fields, including engineering, agricultural technology, and the world wide Web.
Six months ago the U.S. oil industry scored a surprise win against farm groups when the Obama administration proposed slashing the amount of ethanol refiners must blend into gasoline, a move that could save them billions of dollars.
St. Petersburg-based HealBe engages crowdfunding goers at Indiegogo.com for GoBe earning $1,084,311 Tuesday, with the original goal set at $100,000.
Michigan, US-based biopharmaceutical firm ProNAi Therapeutics landed $60 million in its Series D funding round led by Vivo Capital to advance its cancer treatment drugs to the second phase of clinical trials.
